Table 2.
Baseline outcome scores
| Health measures | n | Intervention participants | n | Control participants |
Test statistic; p-value |
|---|---|---|---|---|---|
| SF-12 MCS - mean (SD) | 197 | 43.2 (11.0) | 195 | 49.6 (9.8) | 6.1; p < 0.001a |
| SF-12 PCS - mean (SD) | 197 | 34.7 (11.7) | 195 | 42.8 (12.5) | 6.6; p < 0.001a |
| EQ-5D - mean (SD) | 198 | 0.5 (0.3) | 194 | 0.7 (0.3) | 7.5; p < 0.001a |
| GDS-10 - mean (SD) | 195 | 4.4 (2.4) | 192 | 2.2 (2.2) | -9.3; p < 0.001a |
| Social support | n | n |
Test statistic; p-value |
||
| MOS-6 - mean (SD) | 199 | 2.7 (1.1) | 193 | 3.5 (1.0) | 8.3; p < 0.001a |
| Social activities | n | n |
Test statistic; p-value |
||
| No. friends/family - median (IQR) | 200 | 5 (2, 10) | 193 | 5 (3, 10) | 0.9; p = 0.38a |
| No. clubs/groups - median (IQR) | 199 | 1 (0, 2) | 194 | 1 (0, 2) | 1.4; p = 0.15a |
| Get together with friends/family - n (%) | 199 | 194 | -0.9; p = 0.36b | ||
| Every day | 14 (7.0%) | 16 (8.3%) | |||
| Several days a week | 51 (25.6%) | 50 (25.8%) | |||
| Once a week | 52 (26.1%) | 49 (25.3%) | |||
| 2-3 times a month | 24 (12.1%) | 30 (15.5%) | |||
| Once a month | 16 (8.0%) | 24 (12.4%) | |||
| 5-10 times a year | 11 (5.5%) | 14 (7.2%) | |||
| Less than 5 times a year | 31 (15.6%) | 11 (5.7%) | |||
| Getting along with others - n (%) | 200 | 194 | -1.6; p = 0.11b | ||
| Better | 17 (8.5%) | 16 (8.3%) | |||
| The same | 154 (77.0%) | 164 (84.5%) | |||
| Worse | 29 (14.5%) | 14 (7.2%) | |||
| GHS items | n | n |
Test statistic; p-value |
||
| Work around the house - n (%) | 200 | 16 (8.0%) | 195 | 36 (18.5%) | 9.5; p < 0.01c |
| Transport/errands - n (%) | 200 | 27 (13.5%) | 195 | 59 (30.3%) | 16.3; p < 0.001c |
| Child care - n (%) | 200 | 21 (10.5%) | 195 | 37 (19.0%) | 5.7; p < 0.05c |
| Practical advice - n (%) | 200 | 24 (12.0%) | 195 | 37 (19.0%) | 3.7; p = 0.06c |
| Emotional support - n (%) | 200 | 48 (24.0%) | 195 | 103 (52.8%) | 34.7; p < 0.001c |
| Other - n (%) | 200 | 26 (13.0%) | 195 | 38 (19.5%) | 3.1; p = 0.08c |
| None of the above - n (%) | 200 | 107 (53.5%) | 195 | 55 (28.2%) | 26.1; p < 0.001c |
| Morbidity | n | n |
Test statistic; p-value |
||
| Angina - n (%) | 200 | 30 (15.0%) | 195 | 14 (7.2%) | 6.1; p < 0.05c |
| Arthritis - n (%) | 200 | 92 (46.0%) | 195 | 90 (46.2%) | 0.001; p = 1.0c |
| Cancer - n (%) | 200 | 15 (7.5%) | 195 | 10 (5.1%) | 0.9; p = 0.33c |
| Diabetes - n (%) | 200 | 28 (14.0%) | 195 | 17 (8.7%) | 2.7; p = 0.10c |
| Heart failure - n (%) | 200 | 17 (8.5%) | 194 | 4 (2.1%) | 8.1; p < 0.01c |
| High blood pressure - n (%) | 199 | 98 (49.3%) | 195 | 78 (40.0%) | 3.4; p = 0.07c |
| Sight/hearing problems - n (%) | 200 | 114 (57.0%) | 195 | 73 (37.4%) | 15.2; p < 0.001c |
| Stroke - n (%) | 199 | 13 (6.5%) | 195 | 2 (1.0%) | 8.2; p < 0.01c |
| Depression or anxiety - n (%) | 200 | 127 (63.5%) | 195 | 66 (33.9%) | 34.7; p < 0.001c |
| Memory/concentration problems - n (%) | 200 | 121 (60.5%) | 195 | 79 (40.5%) | 15.8; p < 0.001c |
| Chronic respiratory conditions - n (%) | 200 | 39 (19.5%) | 195 | 30 (15.4%) | 1.2; p = 0.28c |
| Sleeping difficulties - n (%) | 200 | 120 (60.0%) | 195 | 87 (44.6%) | 9.4; p < 0.01c |
a Two-sample t test
b Mann-Whitney U test
c Chi-square test